New chlamydia drug targets discovered using CRISPR and stem cells

(Wellcome Trust Sanger Institute) Scientists at the Wellcome Trust Sanger Institute and their collaborators at the University of British Columbia have created an innovative technique for studying how chlamydia interacts with the human immune system. The results, reported today (April 25) in Nature Communications, identify novel drug targets for the sexually transmitted disease.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news